(Q30276605)

13 October 2017

A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis (English)

1 reference

13 October 2017

0 references

1 reference

James F Howard

14

0 references

Michael Benatar

21

object named as

Michael Benatar

1 reference

13 October 2017

6

Vera Bril

1 reference

13 October 2017

4

Ted M Burns

1 reference

13 October 2017

1

Mamatha Pasnoor

1 reference

13 October 2017

15

Namita Goyal

1 reference

13 October 2017

5

Sharon Nations

1 reference

13 October 2017

7

Annabel K Wang

1 reference

13 October 2017

11

J Aziz Shaibani

1 reference

13 October 2017

12

Carlayne Jackson

1 reference

13 October 2017

20

Tahseen Mozaffar

1 reference

13 October 2017

27

Richard J Barohn

1 reference

13 October 2017

23

Ericka Simpson

1 reference

13 October 2017

Jianghua He

2

1 reference

13 October 2017

Laura Herbelin

3

1 reference

13 October 2017

Bakri H Elsheikh

8

1 reference

13 October 2017

John T Kissel

9

1 reference

13 October 2017

David Saperstein

10

1 reference

13 October 2017

Andrea Swenson

13

1 reference

13 October 2017

William David

16

1 reference

13 October 2017

Matthew Wicklund

17

1 reference

13 October 2017

Michael Pulley

18

1 reference

13 October 2017

Mara Becker

19

1 reference

13 October 2017

Robert Pazcuzzi

22

1 reference

13 October 2017

Jeffrey Rosenfeld

24

1 reference

13 October 2017

Mazen M Dimachkie

25

1 reference

13 October 2017

Jeffrey M Statland

26

1 reference

13 October 2017

Methotrexate in MG Investigators of the Muscle Study Group

28

1 reference

13 October 2017

language of work or name

English

0 references

publication date

15 June 2016

1 reference

13 October 2017

1 reference

13 October 2017

87

1 reference

13 October 2017

1

1 reference

13 October 2017

57-64

1 reference

Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

Methotrexate: new uses for an old drug.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

The myasthenia gravis--specific activities of daily living profile

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

Recommendations for myasthenia gravis clinical trials

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

3 June 2018

Prednisone chronotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

Therapeutic approaches in myositis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

Use of methotrexate in patients with systemic lupus erythematosus and primary Sjögren's syndrome

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

A systematic review of population based epidemiological studies in Myasthenia Gravis.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

The MG Composite: A valid and reliable outcome measure for myasthenia gravis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

Analyzing incomplete longitudinal clinical trial data

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

Reliability testing of the quantitative myasthenia gravis score

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

Immunointervention with cyclosporin A in autoimmune neurological disorders

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4932232

Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27306628

12 December 2020

inferred from PubMed ID database lookup

Myasthenia gravis activities of daily living profile

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27306628

12 December 2020

inferred from PubMed ID database lookup

A simple manual muscle test for myasthenia gravis: validation and comparison with the QMG score

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27306628

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1212/WNL.0000000000002795

1 reference

release_yyhoajodezakplp5rz3r4thmx4

13 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yyhoajodezakplp5rz3r4thmx4

24 November 2022

mapped directly with Wikidata item

1 reference

13 October 2017

1 reference